$LEGN news
The latest LEGN stock news: headlines, filings, AI summaries and sentiment for $LEGN, updated around the clock.
- Legend Biotech Reports Q3 2026 Profitability Driven by CARVYKTI Global Expansion
- Legend Biotech Appoints Ingrid Zhang as New CEO
- Johnson & Johnson's Top Investment Among Its Biotech Holdings
- Leadership Changes at Legend Biotech and Sarepta Therapeutics
- Legend Biotech CEO Ying Huang Steps Down
- Two Biotech Stocks Considered Potential Buyout Targets
- UBS Raises Price Target for Legend Biotech to $49 Based on Positive Clinical Data
- Legend Biotech Shares Rise Sharply Following Positive Phase 1 Trial Results for New Cancer Therapy
- Legend Biotech Nears Adjusted Profitability in 2026 Amid CARVYKTI Growth
- Legend Biotech Reports Strong CARVYKTI Sales Growth in Q1 2026
- Legend Biotech Stock Rises 18% on Analyst Upgrades and Eli Lilly's Acquisition